AFT Pharmaceuticals Limited (AFT.NZ)
NZD 2.75
(-0.36%)
NZD 2.75
(-0.36%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 25.54 Million | 9 Million | 12.22 Million | -2.42 Million | 9.27 Million | -2.49 Million |
| Net Income | 15.6 Million | 10.65 Million | 19.84 Million | 7.78 Million | 12.69 Million | -2.42 Million |
| Depreciation & Amortization | 2.01 Million | 1.72 Million | 1.04 Million | 1.1 Million | 1.1 Million | 319 Thousand |
| Deferred income taxes | - | - | -9.57 Million | -13.88 Million | -1.31 Million | -5.56 Million |
| Stock-based compensation | 139 Thousand | - | 13 Thousand | 44 Thousand | 114 Thousand | 252 Thousand |
| Change in working capital | 1.5 Million | -6.94 Million | -7.47 Million | -11.63 Million | 1 Million | -4.67 Million |
| Other non-cash items | 8.94 Million | 3.57 Million | 8.36 Million | 14.16 Million | -4.32 Million | 9.61 Million |
| Investing Cash Flow | -9.52 Million | -9.17 Million | -5.58 Million | -6.23 Million | -6.56 Million | -4.88 Million |
| Investments in PPE | -9.52 Million | -9.17 Million | -5.58 Million | -6.23 Million | -6.56 Million | -3.46 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -1.41 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -9.41 Million | -8.98 Million | -5.25 Million | -6.13 Million | -6.47 Million | -4.74 Million |
| Financing Cash Flow | -7.32 Million | -6.97 Million | -3.91 Million | 2.52 Million | -9.11 Million | 3.72 Million |
| Debt repayment | -5 Million | -4 Million | -6.13 Million | -6.5 Million | -60.32 Million | -7.41 Million |
| Dividends payments | -1.15 Million | - | - | -188 Thousand | -566 Thousand | -134 Thousand |
| Common Stock Repurchased | - | - | - | -723 Thousand | 52.27 Million | - |
| Common Stock Issuance | - | 475 Thousand | 295 Thousand | 12.39 Million | 3000.00 | - |
| Other Financing Activities | -793 Thousand | -3.45 Million | 1.92 Million | -2.46 Million | -513 Thousand | 11.27 Million |
| Accounts receivables | 2.49 Million | -10.71 Million | -4.96 Million | -4.55 Million | -7.29 Million | -2.05 Million |
| Accounts payables | 5.66 Million | 12.66 Million | -2.66 Million | 3.84 Million | 5.87 Million | -1.87 Million |
| Inventory | -6.66 Million | -8.89 Million | 154 Thousand | -10.92 Million | 2.42 Million | -746 Thousand |
| Other working capital | - | - | - | - | - | -1.00 |
| Cash at beginning of period | 4.74 Million | 7.94 Million | 3.2 Million | 6.11 Million | 6.91 Million | 6.77 Million |
| Cash at end of period | 12.04 Million | 3.29 Million | 7.94 Million | 3.2 Million | 6.11 Million | 6.91 Million |
| Capital Expenditure | -9.52 Million | -9.17 Million | -5.58 Million | -6.23 Million | -6.56 Million | -3.46 Million |
| Effect of forex changes on cash | 48 Thousand | -123 Thousand | 78 Thousand | 49 Thousand | 5000.00 | 240 Thousand |
| Net cash flow / Change in cash | 7.29 Million | -4.64 Million | 4.73 Million | -2.91 Million | -797 Thousand | 146 Thousand |
| Free Cash Flow | 16.02 Million | -173 Thousand | 6.63 Million | -8.65 Million | 2.71 Million | -5.95 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.89 Million | 15.6 Million | 6.89 Million | 1.81 Million | 908 Thousand | 10.65 Million |
| Depreciation & Amortization | 582.5 Thousand | 2.01 Million | 175.5 Thousand | 848 Thousand | 424 Thousand | 1.72 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 69.5 Thousand | - | 69.5 Thousand | - | - | - |
| Change in working capital | -2.61 Million | 1.5 Million | -2.61 Million | 3.94 Million | 528 Thousand | -6.94 Million |
| Other non-cash items | 5.75 Million | 8.94 Million | 6.16 Million | -3.02 Million | 1.87 Million | 3.57 Million |
| Investing Cash Flow | -2.34 Million | -9.52 Million | -2.34 Million | -4.84 Million | -2.42 Million | -9.17 Million |
| Investments in PPE | -20 Thousand | -9.52 Million | -20 Thousand | -4.84 Million | -38 Thousand | -9.17 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.32 Million | -9.41 Million | -2.32 Million | -2.38 Million | -2.38 Million | -8.98 Million |
| Financing Cash Flow | -3.68 Million | -7.32 Million | -3.68 Million | -1.63 Million | -1.63 Million | -6.97 Million |
| Debt repayment | -5 Million | -5 Million | - | - | - | -4 Million |
| Dividends payments | - | -1.15 Million | - | -1.15 Million | -577 Thousand | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 475 Thousand |
| Other Financing Activities | -3.68 Million | -793 Thousand | -3.68 Million | -1.05 Million | -1.05 Million | -3.45 Million |
| Accounts receivables | -5.4 Million | 2.49 Million | -5.4 Million | 13.3 Million | 6.65 Million | -10.71 Million |
| Accounts payables | 2.78 Million | 5.66 Million | - | 2.88 Million | - | 12.66 Million |
| Inventory | 2.79 Million | -6.66 Million | 2.79 Million | -12.25 Million | -6.12 Million | -8.89 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 6.17 Million | 4.74 Million | - | 4.74 Million | - | 7.94 Million |
| Cash at end of period | 12.04 Million | 12.04 Million | 4.72 Million | 6.17 Million | -352 Thousand | 3.29 Million |
| Capital Expenditure | -20 Thousand | -9.52 Million | -20 Thousand | -4.84 Million | -38 Thousand | -9.17 Million |
| Effect of forex changes on cash | 53 Thousand | 48 Thousand | 53 Thousand | -29 Thousand | -29 Thousand | -123 Thousand |
| Net cash flow / Change in cash | 5.86 Million | 7.29 Million | 4.72 Million | 1.42 Million | -352 Thousand | -4.64 Million |
| Free Cash Flow | 10.67 Million | 16.02 Million | 10.67 Million | 984 Thousand | 3.69 Million | -173 Thousand |
IOS
688363
SICALLOG
002021
1732
PANXF